EDGAR Filing Documents for 0001308179-23-000352

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001308179-23-000352

Filing Date

2023-03-24

Accepted

2023-03-24 08:02:04

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMNEAL PHARMACEUTICALS, INC. - DEFA14A	lamrx2023_defa14a.htm	DEFA14A	8670
2	GRAPHIC	check.jpg	GRAPHIC	1441
3	GRAPHIC	logo.jpg	GRAPHIC	14116
4	GRAPHIC	notice_1.jpg	GRAPHIC	70898
5	GRAPHIC	notice_2.jpg	GRAPHIC	57106
6	GRAPHIC	uncheck.jpg	GRAPHIC	1060
	Complete submission text file	0001308179-23-000352.txt		209289

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807

Business Address (908) 947-3120

Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38485 | Film No.: 23757701
SIC: 2834 Pharmaceutical Preparations